BCLI   $2.07  -7.17% Market Closed

Brainstorm Cell Therapeutics Inc
Total Cash 3.47M
totalCashPerShare 0.653
EBITDA -16.04M
Total Debt 962.00K
quickRatio 0.455
currentRatio 0.496
Total Revenue
debtToEquity
Revenue/Share
ROA -1.78204
ROE
grossProfits
freeCashflow -8.45M
operatingCashflow -14.44M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 6.42M
forwardPE -0.7154471
floatShares 4.27M
sharesOutstanding 5.32M
sharesShort 165.89K
sharesShortPriorMonth 93.27K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.15%
Short Ratio help_outline 2.85%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -0.664
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -12.75M
trailingEps -3.30%
forwardEps -2.46%
enterpriseToEbitda -0.40
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.57 3Q 2024
institutionsCount 47
lastUpdated Nov. 6, 2024, 6:26 p.m.